AVIR · Atea Pharmaceuticals, Inc.
Market Cap
$467.59M
Shares
80.20M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jean-Pierre Sommadossi | President, Chief Executive Officer and Chairman of the Board | $3,403,752 |
| Janet Hammond | MD, PhD Chief Development Officer | $1,767,234 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal | $1,690,428 |
| Dr. Maria Arantxa Horga | Chief Medical Officer | $1,593,827 |
| John Vavricka | Chief Commercial Officer | $1,217,738 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jean-Pierre Sommadossi | President, Chief Executive Officer and Chairman of the Board | $4,202,323 |
| Janet Hammond | MD, PhD Chief Development Officer | $2,159,031 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal | $1,931,832 |
| Dr. Maria Arantxa Horga | Chief Medical Officer | $1,853,306 |
| John Vavricka | Chief Commercial Officer | $1,386,663 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jean-Pierre Sommadossi | President, Chief Executive Officer and Chairman of the Board | $5,925,790 |
| Janet Hammond | MD, PhD Chief Development Officer | $2,107,297 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal | $1,961,524 |
| Dr. Maria Arantxa Horga | Chief Medical Officer | $1,849,189 |
| Wayne Foster | Executive Vice President, Chief Accounting Officer | $1,518,987 |
| John Vavricka | Chief Commercial Officer | $1,515,658 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jean-Pierre Sommadossi | President, Chief Executive Officer and Chairman of the Board | $5,878,026 |
| Janet Hammond | MD, PhD Chief Development Officer | $2,112,151 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal | $1,959,897 |
| Dr. Maria Arantxa Horga | Chief Medical Officer | $1,845,513 |
| John Vavricka | Chief Commercial Officer | $1,522,843 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jean-Pierre Sommadossi | President, Chief Executive Officer and Chairman of the Board | $34,104,892 |
| Janet Hammond | M.D., Ph.D. Chief Development Officer | $9,007,023 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal | $8,357,169 |
| Dr. Maria Arantxa Horga | Chief Medical Officer | $8,136,376 |
| John Vavricka | Chief Commercial Officer | $6,599,415 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Janet Hammond | M.D., Ph.D. Chief Development Officer | $4,030,318 |
| Jean-Pierre Sommadossi | President, Chief Executive Officer and Chairman of the Board | $2,886,987 |
| Nathanial Brown | Former Chief Medical Officer | $2,596,784 |
| Dr. Maria Arantxa Horga | Chief Medical Officer | $2,149,064 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal | $1,488,000 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jean-Pierre Sommadossi | President, Chief Executive Officer and Chairman of the Board | $811,080 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal | $440,324 |
Key facts
CIK
1593899
CUSIP
04683R106
13F (30d)
86 filings
86 filers
Visit website
Investor relations